NEW YORK (GenomeWeb News) — French company Laboratoires Fournier will license BioBase’s TRANSFAC eukaryotic gene-regulation database, BioBase said today.
 
BioBase said the Dijon-based company will use the database to develop therapeutics for metabolic and cardiovascular diseases.
 
BioBase, headquartered in Wolfenbuttell, Germany, said the TRANSFAC database holds information on 8,700 transcription factors and is used to identify and analyze binding sites.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.